Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

被引：0

作者：

Vallerie V. McLaughlin

Pavel Jansa

Jens E. Nielsen-Kudsk

Michael Halank

Gérald Simonneau

Ekkehard Grünig

Silvia Ulrich

Stephan Rosenkranz

Miguel A. Gómez Sánchez

Tomás Pulido

Joanna Pepke-Zaba

Joan Albert Barberá

Marius M. Hoeper

Jean-Luc Vachiéry

Irene Lang

Francine Carvalho

Christian Meier

Katharina Mueller

Sylvia Nikkho

Andrea M. D’Armini

机构：

[1] University of Michigan Health System,Department of Cardiological Medicine

[2] Cardiology and Angiology Department,Thoraxclinic

[3] General University Hospital,Clinic of Pulmonology

[4] Aarhus University,Department III of Internal Medicine

[5] University Hospital Dresden,Unidad de I. Cardiaca e Hipertensión Pulmonar

[6] Hôpital Bicêtre,Department of Pulmonary Medicine, Hospital Clínic

[7] Université Paris-Sud,IDIBAPS

[8] Laboratoire d’Excellence en Recherche sur le Médicament et Innovation Thérapeutique,Département de Cardiologie, Hôpital Erasme

[9] and INSERM Unité 999,Allgemeines Krankenhaus der Stadt Wien

[10] University Hospital Heidelberg,Division of Cardiothoracic Surgery, Foundation “IRCCS Policlinico San Matteo”

[11] University Hospital Zurich,undefined

[12] Cologne University Heart Center,undefined

[13] Hospital Universitario 12 de Octubre,undefined

[14] Instituto Nacional de Cardiología,undefined

[15] National Pulmonary Vascular Diseases Unit,undefined

[16] Papworth Hospital,undefined

[17] University of Barcelona,undefined

[18] and Biomedical Research Networking Center on Respiratory Diseases,undefined

[19] Clinic for Respiratory Medicine,undefined

[20] Hannover Medical School,undefined

[21] Université Libre de Bruxelles,undefined

[22] Medizinische Universität Wien,undefined

[23] Global Development,undefined

[24] Global Medical Affairs,undefined

[25] Bayer AG,undefined

[26] Global Clinical Development,undefined

[27] University of Pavia School of Medicine,undefined

来源：

BMC Pulmonary Medicine | / 17卷

关键词：

Riociguat; Chronic thromboembolic pulmonary hypertension; Early access study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 104 条

[1]

Lang IM(2008)Chronic thromboembolic pulmonary hypertension: an updated review Curr Opin Cardiol 23 555-559

[2]

Klepetko W(2006)Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension Proc Am Thorac Soc 3 608-614

[3]

Peacock A(2009)Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 S43-S54

[4]

Simonneau G(2015)Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension Eur Respir Rev 24 263-271

[5]

Rubin L(2011)Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension J Thorac Cardiovasc Surg 141 383-387

[6]

Simonneau G(2011)Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry J Thorac Cardiovasc Surg 141 702-710

[7]

Robbins IM(2016)Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the UK national cohort Circulation 133 1761-1771

[8]

Beghetti M(2009)First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension Eur Respir J 33 785-792

[9]

Channick RN(2015)Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2) Eur Respir J 45 1293-1302

[10]

Delcroix M(2016)Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial Lancet Respir Med 4 372-380

← 1 2 3 4 5 6 7 8 9 10 →